Pharmaceutical composition
US8821927B2 · kind B2 · utility
2Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2006 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Jun 12, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.